Showing results (471-480 of 579) with videos related to

Sort By:
Pageof 58
Cancer Research|May 17, 2014
Cyclin D1 integrates estrogen-mediated DNA damage repair signalingZhiping Li, Ke Chen, Xuanmao Jiao, et al.
Infection and Immunity|September 20, 2006
Caveolin-1-deficient mice show defects in innate immunity and inflammatory immune response during Salmonella enterica serovar Typhimurium infectionFreddy A Medina, Cecilia J de Almeida, Elliott Dew, et al.
Cell Cycle (Georgetown, Tex.)|May 19, 2009
Towards a new "stromal-based" classification system for human breast cancer prognosis and therapyAgnieszka K Witkiewicz, Mathew C Casimiro, Abhijit Dasgupta, et al.
Cell Cycle (Georgetown, Tex.)|December 2, 2011
Mitochondrial oxidative stress in cancer-associated fibroblasts drives lactate production, promoting breast cancer tumor growth: understanding the aging and cancer connectionRenee M Balliet, Claudia Capparelli, Carmela Guido, et al.
Cell Cycle (Georgetown, Tex.)|April 23, 2011
Ketones and lactate increase cancer cell "stemness," driving recurrence, metastasis and poor clinical outcome in breast cancer: achieving personalized medicine via Metabolo-GenomicsUbaldo E Martinez-Outschoorn, Marco Prisco, Adam Ertel, et al.
Cancer Research|August 3, 2005
Cyclin D1 antagonizes BRCA1 repression of estrogen receptor alpha activityChenguang Wang, Saijun Fan, Zhiping Li, et al.
Cell Cycle (Georgetown, Tex.)|December 13, 2005
Contrast-enhanced in vivo imaging of breast and prostate cancer cells by MRIOlga Rodriguez, Stanley Fricke, Christopher Chien, et al.
Molecular Endocrinology (Baltimore, Md.)|November 15, 2000
Constitutive and growth factor-regulated phosphorylation of caveolin-1 occurs at the same site (Tyr-14) in vivo: identification of a c-Src/Cav-1/Grb7 signaling cassetteH Lee, D Volonte, F Galbiati, et al.
Cell Cycle (Georgetown, Tex.)|February 2, 2008
Regulation of host cell cyclin D1 by Trypanosoma cruzi in myoblastsBoumediene Bouzahzah, Vyacheslav Yurchenko, Fnu Nagajyothi, et al.
Oncotarget|August 28, 2015
Estrogen related receptor α (ERRα) a promising target for the therapy of adrenocortical carcinoma (ACC)Ivan Casaburi, Paola Avena, Arianna De Luca, et al.
Pageof 58